Home/Filings/4/0000950170-24-129380
4//SEC Filing

Chee Conley 4

Accession 0000950170-24-129380

CIK 0001556263other

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 5:00 PM ET

Size

5.0 KB

Accession

0000950170-24-129380

Insider Transaction Report

Form 4
Period: 2024-11-18
Chee Conley
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2024-11-18$0.20/sh134,797$26,9320 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1836 to $0.2071, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Documents

1 file

Issuer

Syros Pharmaceuticals, Inc.

CIK 0001556263

Entity typeother

Related Parties

1
  • filerCIK 0001883804

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:00 PM ET
Size
5.0 KB